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Abstract  
Mild cognitive impairment (MCI) is prevalent in 15-40% of Parkinson’s disease (PD) patients 
at diagnosis. In this investigation, we study brain intra- and inter-network alterations in 
resting state functional magnetic resonance imaging (rs-fMRI) in recently-diagnosed PD 
patients and characterise them as either cognitive normal (PD-NC) or with MCI (PD-MCI). 
Patients were divided into two groups, PD-NC (N=62) and PD-MCI (N=37) and for 
comparison, healthy controls (HC, N=30) were also included. Intra- and inter-network 
connectivity were investigated from participants’ rs-fMRIs in 26 resting state networks 
(RSNs). Intra-network differences were found between both patient groups and HCs for 
networks associated with motor control (motor cortex), spatial attention and visual 
perception. When comparing both PD-NC and PD-MCI, intra-network alterations were found 
in RSNs related to attention, executive function and motor control (cerebellum). The inter-
network analysis revealed a hyper-synchronisation between the basal ganglia network and 
the motor cortex in PD-NC compared to HCs. When both patient groups were compared, 
intra-network alterations in RSNs related to attention, motor control, visual perception, and 
executive function were found. We also detected disease-driven negative synchronisations 
and synchronisation shifts from positive to negative and vice versa in both patient groups 
compared to HCs. The hyper-synchronisation between basal ganglia and motor cortical 
RSNs in PD and its synchronisation shift from negative to positive compared to HCs, 
suggest a compensatory response to basal dysfunction and altered basal-cortical motor 
control in the resting state brain of PD patients. 
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Introduction 
Parkinson’s disease dementia (PDD) is a frequent complication of PD with a cumulative 
incidence approaching 80% (Hely, et al., 2008). Mild cognitive impairment associated with 
PD (PD-MCI) is recognised as a clinical entity with a prevalence of 15-40% at PD diagnosis 
and is a risk factor for the subsequent development of PDD (Yarnall, et al., 2014). Both PD-
MCI and PDD contribute to a poorer quality of life (Lawson, et al., 2014), with PDD resulting 
in increased falls, neuropsychiatric disturbance, increased carer burden, loss of 
independence and higher likelihood of nursing home placement (Yarnall, et al., 2013).   
PD-MCI as defined by the Movement Disorders Society (MDS) Task Force (Litvan, et al., 
2012) encompasses cognitive deficits of executive, attention, memory, language and 
visuospatial functions. The underlying pathology of the motor aspects of PD is relatively well 
understood with established evidence-based therapies (Fox, et al., 2011). However, the 
aetiology underlying cognitive deficit in PD is less well known. At the cellular level, there is 
high variability in Lewy body-related pathological load and in the distribution of the pathology 
in cortical and subcortical structures. Furthermore, there remains an undetermined role for 
additional concurrent pathologies such as neurofibrillary tangles, tau and amyloid-β 
deposition in PD, although these are associated cognitive decline (Halliday, et al., 2011; 
Irwin, et al., 2013) and dynamic changes in neurotransmitter pathways (Kehagia, et al., 
2010) are also a major feature. Consequently, there is a high degree of heterogeneity in the 
type and severity of non-motor symptoms in patients with PD-MCI and PDD (Galvin, et al., 
2006; Parkkinen, et al., 2008).  
Though the cellular level pathologies are diverse and complex, they do result in brain-wide 
neural system dysfunctions which are more amenable to investigation (Gratwicke, et al., 
2015). These macro level functional alterations have the potential to be biomarkers of 
disease progression, particularly when related to the cognitive changes seen in PD, and one 
methodology employed to measure this is resting state functional magnetic resonance 
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imaging (rs-fMRI). Independent component analysis (ICA), in particular, is a powerful data-
driven method that decomposes rs-fMRI data into resting state networks (RSNs). These 
RSNs are associated with distinct brain functions (Baggio, et al., 2015a), and can show 
changes or functional alterations which are specific to a particular disease (Dipasquale, et 
al., 2015). 
The most widely reported RSN, the default mode network (DMN), plays an active role in 
cognitive processing with previous studies showing impaired deactivation in PD-MCI (van 
Eimeren, et al., 2009) and ‘over activity’ in PD (Shine, et al., 2014; Shine, et al., 2011). It is 
dynamically linked to several other cognitive networks, including the dorsal attentional 
network (DAN) and ventral attention network (VAN), both of which also show connectivity 
changes in PD-MCI (Baggio, et al., 2015b; Peraza, et al., 2015a; Shine, et al., 2014). As a 
collective, the DMN, DAN and VAN, together with several other RSNs, underlie specific 
cognitive processes such as attention, xecutive and motor functions.  
The aim of this study was to quantify changes in rs-fMRI intra and inter-network connectivity 
in early PD and PD-MCI using high dimensional ICA, dual regression and informative 
network connectivity measures (Filippini, et al., 2009). We hypothesised that participants 
with PD and, in particular, those with PD-MCI, would show functional connectivity alterations 
in the DMN, DAN and VAN, and that there would be changes in connectivity both within and 
between these networks. 
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Methods 
Recruitment and clinical assessments 
Participants with a new diagnosis of PD were recruited from clinics in Newcastle upon Tyne 
and Gateshead areas of the UK as part of the Incidence of Cognitive Impairment in Cohorts 
with Longitudinal Evaluation in PD (ICICLE-PD) study (Yarnall, et al., 2014). The diagnosis 
of PD was made by a movement disorder specialist utilising the United Kingdom Parkinson’s 
Disease Society Brain Bank Criteria for idiopathic PD (Hughes, et al., 2002), with 
reconfirmation after 18 months from their first assessment. Exclusion criteria included 
Parkinsonism diagnosed before study launch, insufficient English proficiency to complete 
neuropsychological assessments, advanced cognitive impairment (Mini-Mental State 
Examination, MMSE < 24) or dementia at diagnosis (Emre, et al., 2007), and suggestive 
diagnosis of other brain conditions and Parkinsonian diseases such as dementia with Lewy 
bodies (DLB), progressive supranuclear palsy, and repeated strokes (Duncan, et al., 2015; 
Yarnall, et al., 2014). Additionally, unrelated healthy control participants (HCs) were enrolled 
from community sources in Newcastle/Gateshead to provide normative data. The study was 
approved by the Newcastle and North Tyneside Research Ethics Committee and all subjects 
provided written informed consent.  
Study participants completed a battery of neuropsychological tests: MMSE, the Montreal 
cognitive assessment (MoCA) (Nasreddine, et al., 2005), selected tests from the Cambridge 
Neuropsychological Test Automated Battery (CANTAB: Tower of London, Paired Associates 
Learning (PAL), Spatial Recognition Memory (SRM), Pattern Recognition Memory (PRM), 
semantic fluency and phonetic fluency) (Robbins, et al., 1994). Power of attention (PoA) was 
estimated as a composite score of simple reaction time, choice reaction time and digit 
vigilance from the Cognitive Drug Research (CDR) battery. Motor disease severity was 
assessed with the revised Movement Disorder Society Unified Parkinson’s Disease Rating 
Scale (MDS-UPDRS) part III (Goetz, et al., 2008). The National Adult Reading Test (NART) 
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(Mathias, et al., 2007) was used to estimate premorbid levels of intelligence. Patients were 
assessed and underwent MRI scanning in the “ON” state; i.e. taking their usual 
dopaminergic medication, which was standardised to the Levodopa equivalent daily dose 
(LEDD) (Tomlinson, et al., 2010). 
In agreement with previous studies (Duncan, et al., 2015; Mak, et al., 2015; Yarnall, et al., 
2014), we applied recommended modified level II MDS criteria (Litvan, et al., 2012) for the 
diagnosis of PD-MCI with a threshold of 1.5 standard deviations (SD) below normative 
values (HCs). The level II MDS criteria establish that patients below this threshold in at least 
two neuropsychological tests assessing five cognitive domains (attention, execution, 
visuospatial, memory and language) would qualify for the diagnosis of PD-MCI. A complete 
description of the participants’ clinical and neuropsychological assessments can be found in 
Yarnall, et al. (2014). 
MRI acquisition and pre-processing 
A total of 32 HC and 121 PD participants had brain resting state functional (rs-fMRI) and 
structural (MRI) taken with a 3 Tesla Philips Intera Achieva scanner. Structural images were 
obtained with a magnetisation prepared rapid gradient-echo sequence (MP-RAGE), sagittal 
acquisition, echo time 4.6 ms, repetition time 8.3 ms, inversion time 1250 ms, flip angle=8 
degrees, sensitivity encoding factor=2, and in plane field of view of 240 x 240 mm with slice 
thickness of 1.0 mm. For the rs-fMRI, participants were asked to lie inside of the scanner 
with their eyes closed during the recording. Functional images were acquired with a 
gradient-echo planar imaging sequence with 25 contiguous axial slices, in-plane resolution = 
2x2 mm, slice thickness of six mm, and repetition time of three seconds. A total of 128 fMRI 
volumes were obtained per participant. 
Images were pre-processed using FSL (FMRIB Software Library version 5.0, 
http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/). Functional images were slice timing and motion 
corrected. Additionally, to further reduce artefactual influences, the six movement 
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parameters (rotations and translations), and the cerebrospinal fluid signal from the lateral 
ventricles were regressed out using the Resting-State fMRI Data Analysis Toolkit (REST) 
(Song, et al., 2011) in Matlab (MATLAB 7.14, The MathWorks Inc., Natick, MA, USA). 
Finally, functional and structural images were linearly coregistered to the MNI (Montreal 
Neurology Institute) standard space. Functional images were spatially resampled to 4x4x4 
mm voxel size, high pass filtered (150 seconds) and spatially smoothed with a six mm 
FWHM (full width half maximum) filter. 
In order to maximise data quality for this study, we applied a conservative exclusion criteria 
for movement within the MRI scanner; those participants that moved >2 mm translation or 
>1º rotation were excluded from the analysis (Liao, et al., 2010; Peraza, et al., 2015b). 
Independent component analysis and dual regression 
The multivariate exploratory linear optimized decomposition into independent components 
(MELODIC) algorithm within FSL was implemented to estimate canonical RSNs (Beckmann, 
et al., 2005). For this, a high dimensional group concatenated MELODIC was run in the HC 
group to obtain 70 independent component maps; this number of components is 
recommended in order to obtain accurate maps for subcortical brain regions (Abou Elseoud, 
et al., 2011; Dipasquale, et al., 2015). Component maps were visually analysed in their 
spatial and spectral content (Kelly Jr, et al., 2010) and 26 RSNs were identified as being of 
biological interest according to the previous literature (Agosta, et al., 2012; Beckmann, et al., 
2005; Damoiseaux, et al., 2008), see Figure 1. 
FSL-dual regression (Filippini, et al., 2009) was implemented to assess intra-RSN 
connectivity. Briefly, dual-regression spatially regresses the canonical RSNs on each 
participant’s fMRI to extract a representative time series per map (first regression). 
Posteriorly, these time series are regressed again onto each participant’s fMRI (second 
regression) in order to obtain the individual RSN maps, which are used for group 
comparisons. Prior to dual-regression, the 26 RSNs were concatenated in a single 4D file for 
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the dual-regression algorithm. In this way, the algorithm evaluates each RSN while the 
remaining 25 are used as spatial covariates. 
Assessing inter-network connectivity 
Inter-network connectivity was investigated using FSL-Nets 
(http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSLNets). This method takes the time series from the first 
regression in the dual-regression analysis to create inter-network connectivity matrices, 
which were estimated in this investigation using normalised covariance and transformed to 
Fisher-z scores as implemented in the FSL-Nets tool. 
Statistical analysis 
Group differences in age were assessed with a one-way ANOVA for the HC, PD-NC and 
PD-MCI groups. Gender differences were studied with a χ2 test. Years of education and 
NART differences among the three groups were assessed with Kruskal-Wallis tests. Disease 
duration was assessed with a Mann-Whitney test between patient groups. LEDD, MDS-
UPDRS III, MMSE, and MoCA were analysed for statistical comparisons with standard 
student t-tests between both patient groups. The remaining clinical variables were compared 
with Mann-Whitney tests when variables didn’t show a Gaussian distribution. 
Between-group comparisons for the dual-regressed maps were implemented using the 
general linear model (GLM) and significant differences were analysed with the FSL-
randomise function (10,000 permutations). All results from FSL-randomise were corrected 
for multiple comparisons using threshold-free cluster enhancement (TFCE) and were 
considered significant at a p-value<0.05. Age, gender, and years of education were included 
as covariates of no interest in all GLM designs. For comparisons between patient groups, 
LEDD was also included as a covariate of no interest (Tahmasian, et al., 2015).  
For the inter-network analysis with FSL-Nets, between group differences were also 
assessed with FSL-randomise (10,000 permutations) using the same strategy for the 
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covariates of no interest as in the dual-regression (see above). Inter-network connectivity 
differences were taken as significant at a p-value<0.05 FWE corrected for multiple 
comparisons. 
Significant intra and inter-network between group differences were investigated for 
associations with clinical variables that contributed to the MCI diagnostic criteria. For 
the intra-network relations a voxelwise GLM was fitted using the fsl_glm function as 
follows; dual-regression result ~ clinical variable + age + gender + years of education 
+ LEDD. For the results comparing against HCs only the patient groups were fitted to 
the GLM model and for the results comparing patient groups, the entire PD cohort 
was fitted to the model. Significance was assessed with nonparametric permutations 
(FSL-randomise, 1000 permutations) and TFCE correction for multiple voxel 
comparisons (p-value < 0.05 corrected). Similarly, the GLM was applied to investigate 
relationships between clinical variables and inter-network connectivity differences 
from FSL-Nets. The clinical variables investigated in were: MoCA, Power of Attention, 
Digit Vigilance Accuracy, PRM, SRM, UPDRS III, Tower of London, Animal naming, 
Language total score, and PAL (Yarnall, et al., 2014). 
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Results 
From the cohort of participants, two HCs and 12 PD patients were excluded due to artefacts 
and vascular infarcts in their functional and structural MRIs respectively. Additionally, 10 PD 
patients were also excluded due to the motion exclusion criteria (>2 mm translation). After 
exclusions, 30 HCs and 99 PD patients remained for further functional analysis. From the 
cohort of PD patients, 62 were diagnosed as PD with normal cognition (PD-NC) and 37 as 
PD-MCI according to the MDS level II (Lawson, et al., 2014). 
The three groups were assessed for movement differences within the scanner. This test 
showed a significant difference in total translational movement (Kruskal Wallis: χ2=7.42, p-
value=0.024, df=2) but not in rotational movement. A post-hoc t-test revealed that this 
difference was driven by the PD-NC group which, on average, moved more than the HCs (p-
value = 0.006) but not significantly more than the PD-MCI group (p-value = 0.83). 
Statistical comparisons of demographic and clinical variables are shown in Table I. Those 
with PD-MCI were significantly older, had greater LEDD and had lower educational 
attainment compared to both the PD-NC and HC groups. As expected, the PD-MCI group 
performed worse in cognitive assessments when compared to PD-NC and HCs and were 
more medicated compared with the PD-NC. 
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Dual-regression and FSL-Nets 
The 26 RSNs of interest were investigated by dual-regression for intra-network related 
changes; representative contrast maps are shown in Figure 2. Significant clusters are shown 
in Table II, labelled by RSN and cluster index for the three between-group comparisons. In 
general, when comparing patient groups to HCs, we found a decrease in functional 
connectivity in the patient groups. When comparing HC and PD-NC groups, lower functional 
synchronisations were found in the PD-NC group for the RFPN, DAN, MN2, and FPN. 
Conversely, increased synchronisations in the PD-NC group were found for the LFPN at the 
left subcallosal cortex when compared to HCs. 
When comparing HCs with the PD-MCI group, lower functional synchronisations were found 
in PD-MCI for the VN2, DAN and TEMP networks. Comparisons between both patient 
groups, PD-NC and PD-MCI, showed significantly lower synchronisation in the MCI group for 
the VAN, and dmPFN. Higher synchronisation in the PD-MCI group when compared to PD-
NC was found for cerebellar and insular networks; CBN2 and INSN (see Table II). 
However, when analysing individual clusters, we noted that some of the significant 
decreases in functional synchronisation were, in actuality, negative synchronisations in 
functional connectivity or anticorrelations (Keller, et al., 2013), i.e. the absolute connectivity 
in these cases was higher in patients than in HCs; see for instance clusters FPN-20, DAN-08 
or VN2-25 whose summarised values are shown in the boxplots in Figures 3A-B. 
Comparisons between both patient groups, PD-NC and PD-MCI, also showed increased 
anticorrelations for the PD-MCI patients, e.g. cluster VAN-29 in Figure 3C. 
Inter-network brain connectivity was assessed with FSL-Nets, with the objective to determine 
differences in connectivity between the identified RSNs. Figures 4A-C show the within-group 
mean connectivity matrices. Between-group comparisons for the connectivity matrices 
revealed a significantly increased synchronisation in PD-NC group compared with HCs 
between the basal network BS1 and the motor network MN1 (p-value <0.05 , FWE corrected 
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for multiple comparisons). A post-hoc analysis of these inter-network values revealed that 
this increased synchronisation was a result of a shift from a negative to positive 
synchronisation in the PD-NC group (Figure 4D). In PD-MCI, this synchronisation change 
although also present, did not reach significance after correction for multiple comparisons 
when compared against HCs. 
Several intra-network connectivity clusters (Table II) significantly related to the 
clinical variables, see Table III. Spatial and Pattern recognition memory (SRM, PRM), 
Power of Attention (PoA), paired associates learning (PAL), MoCA, and Tower of 
London test significantly correlated with dual-regressed results. The most significant 
relation occurred between cluster FPN-20 and the SRM variable. This cluster 
demonstrated a disconnection between the frontal pole network and the right middle 
frontal gyrus. For the only significant inter-network difference (BS1-MN1), we detected 
a significant positive relation between this inter-network connectivity and PAL 
(coefficient B1 = 1.59, p-value = 0.045, R
2=0.25, SE=2.18). 
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Discussion  
We studied functional connectivity in patients diagnosed with PD with normal cognition (PD-
NC) and PD-MCI. In general, our dual regression analyses found lower functional 
synchronisations in the patient groups when compared to HCs. An analysis of the significant 
clusters revealed that some of the apparent synchronisation decreases in the patient groups 
were actually a reflection of increases in negative synchronisations which are commonly 
referred to as anticorrelations (Keller, et al., 2013). Our analysis examining connectivity 
between networks with FSL-Nets found increased synchronisation between one of the 
identified basal ganglia networks, BS1, and motor networks, MN1 in both patient groups 
compared to HCs. 
 
Lower and higher functional synchronisations in PD-NC and PD-MCI 
The PD-NC group demonstrated lower synchronisations for RSNs related to attention 
(RFPN, DAN), motor control (MN2), and memory recall and execution (FPN) when 
compared to HCs. The RFPN showed a decreased connectivity in the right supramarginal 
gyrus, a region related to space perception and limb location (de Schotten, et al., 2005). The 
DAN network showed significantly reduced connectivity in the right precentral gyrus that 
suggests a disconnection between this primarily attentional network and the right 
sensorimotor and frontal cortices. A similar finding was found in the PD-MCI group but with a 
smaller cluster in the right frontal pole.  
For the motor network MN2, we found reduced connectivity with occipital and parietal 
cortices. Lower connectivity between this network and the occipital and parietal regions was 
also reported by Peraza, et al. (2014) in dementia with Lewy bodies (DLB). This dementia is 
also characterised by the presence of Parkinsonism and visuospatial and attentional 
impairments. Specifically, significant regions from the MN2 related with PoA which 
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assesses attention function. Similarly, the FPN-20 cluster significantly related with 
SRM at several brain regions such as the right middle frontal gyrus, which aligns 
again with expected attention and executive deficits (Talati and Hirsch, 2005). 
The only network that showed higher connectivity in the PD-NC group compared to HCs was 
the LFPN network with the left subcallosal cortex. The LFPN is one of the attentional 
networks with the highest activity in the supramarginal gyrus which links this network to 
spatial attention. Its increased synchronisation with the subcallosal cortex is difficult to 
interpret in PD. However, this region showed a positive relation with the PRM and 
Tower of London tests, the latter test being related to executive function. The higher 
connectivity in PD-NC patients and the positive relation with the clinical variables 
suggests a possible compensation mechanism in cognitively intact PD patients. 
For the PD-MCI group when comparing to HCs, differences were found for RSNs related to 
vision (VN2), attention (DAN), and hearing (TEMP). Both the VN2 and TEMP networks 
showed apparent lower connectivity with the primary motor cortices while the DAN had 
apparent lower connectivity with the right frontal pole, which a post-hoc analysis revealed to 
be a result of negative synchronisations. Functional alterations in PD-MCI between the 
DAN and frontal regions have been reported before (Baggio, et al., 2015b) and would 
map onto attention/executive deficits in PD-MCI, although we did not find a significant 
relation with any clinical variables in the current cohort. The lower functional 
connectivity between auditory and visual related networks with the pre- and 
postcentral cortices, related negatively with the PAL test. The PAL test assesses new 
learning through a visual recognition task and this may map onto visual and memory 
impairments in PD-MCI. 
When we compared both patient groups, the RSN that showed the broadest differences was 
the dorso-medial pre-frontal network (dmPFN) with the left frontal cortex, mainly the middle 
frontal and precentral gyri. This network is part of the fronto-basal-ganglia system which 
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previous investigations related to motor control and cognition (Aron, et al., 2007; Aron and 
Poldrack, 2006). This aligned with the positive relationship between dmPFN clusters in 
the pre- and postcentral gyri and the Tower of London test which assesses executive 
function and planning. The MoCA also related with the VAN-28 cluster at the right 
precentral and cingulate gyri which may reflect the cognitive deficits in PD. 
The PD-MCI group demonstrated increased synchronisations for the insula network INSN 
and cerebellar network CBN2 with the lateral occipital and subcallosal cortices, when 
compared with PD-NC patients. The insula network, also referred to as the salience network, 
is commonly associated with orienting attention to a stimulus (Seeley, et al., 2007). The 
insula has been reported as functionally impaired in the Lewy body diseases (Roquet, et al., 
2016) and it has been associated with complex visual hallucinations (Blanc, et al., 2014) and 
thus despite the absence of visual hallucinations in our PD-MCI cohort early changes in the 
insula network may be an important pre-requisite to these phenomena particularly as 
cognitive symptoms progress.  
 
Negative synchronisations in Parkinson’s disease 
The negative synchronisations observed in the present study (see Figure 3) revealed by our 
dual regression analyses show a characteristic that is commonly neglected in many 
functional studies: anticorrelations. Positive synchronisations can be interpreted as a 
function of direct communication between two brain regions working in synchrony and 
mediated by excitatory connections (Keller, et al., 2013). However, negative 
synchronisations or anticorrelations are not easily interpreted (Chai, et al., 2012) and shifts 
from positive to negative correlations in patient groups are even more challenging to 
understand. Nevertheless, recent evidences have shown that negative synchronisations in 
fMRI have a biological origin (Keller, et al., 2013; Liang, et al., 2012), with current 
hypotheses suggesting that they are an expression of inhibitory brain mechanisms between 
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two or more neuronal systems driven by allocation of functional resources (Coombs Iii, et al., 
2014; Schafer, et al., 2012), or a dynamic self-regulatory process which optimises brain 
function in a constantly changing sensory environment, such as the dynamic interrelation 
between the anticorrelated DAN and DMN (Fox, et al., 2005).  
Shifting from positive to negative synchronisations or vice versa in patient groups might be 
driven by compensatory mechanisms in the presence of the disease. Previous investigations 
have reported the spreading of RSN synchronisations in neurodegenerative patient groups, 
and have been interpreted as an attempt by the RSN in question to control resources of a 
secondary system altered by disease (Gorges, et al., 2015). Our observations of negative 
synchronisations or anticorrelations certainly demand further investigation in order to 
understand their role in neurodegenerative diseases.  
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Hyper cortico-basal network connectivity in PD-NC  
We observed that the PD-NC group presented with higher mean connectivity than HCs and 
PD-MCI group. However, FSL-Nets only showed a significant increase in functional 
connectivity between the BS1 and MN1 networks in the PD-NC group compared with HCs 
and this significantly related positively with PAL test. Recent research suggests that in Lewy 
body diseases, increased connectivity can occur at an early stage in the disease process 
(Gorges, et al., 2015). This may reflect the recruitment of additional neuronal circuitry 
needed to compensate for the presence of neuropathology in the primary neural network 
responsible for a given function, as explained previously. Furthermore, we observed that the 
cortico-basal connectivity between BS1 and MN1 was significantly greater in PD-NC than 
the HC group, which corresponded to a shift from negative to positive connectivity, although 
connectivity in neither group was significantly different to zero. A similar finding was reported 
by Yu et al. in 2013 using a ROI analysis between the putamen and the SMA (Yu, et al., 
2013). As discussed in the previous section, functional anticorrelations in a healthy brain 
might relate to self-regulatory interactions between neural networks. Following this logic, the 
shift from negative to positive synchronisation observed in this study between the basal 
ganglia and motor cortex in PD, may represent a negotiating mechanism of motor control 
that has become dysfunctional in the presence of the pathology.  
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Limitations 
There are some limitations within our present study. First, our patients were on dopaminergic 
medication and scanned in their “ON” state, which might alter functional connectivity. 
However, previous investigations have shown that Levodopa replacement therapy tends to 
normalise functional activity towards HC levels (Tahmasian, et al., 2015); despite this, we 
still found significant functional connectivity alterations. Related to this, our patients were 
also assessed with a battery of neuropsychological tests which were used for the diagnosis 
of MCI. As demonstrated in previous reports on this cohort (Yarnall et al. 2014) and 
consistent with findings in other cohorts (Cholerton et al. 2014) there is substantial 
heterogeneity in cognitive subdomain deficits experienced by PD-MCI patients which raises 
difficulties in terms of interpretation. Study of the different MCI subtype profiles in our cohort 
will require a stratified statistical analysis with a larger cohort which is beyond the scope of 
the current study although it is a focus of our ongoing work.  
Another concern is years of education, which differ between the patient groups especially 
PD-NC and PD-MCI, which might be an important confounder related to cognitive reserve 
and functional brain activity. We reduced the influence of years of education and medication 
(LEDD) by including these variables as covariates of no interest in our analyses. A third 
factor is motion within the scanner; total head movement index was higher in the PD-NC 
group than in HCs. However, our PD-NC group moved less than two mm within the scanner 
which was within our motion inclusion criteria, and correction for motion was applied by the 
FSL toolbox. Additionally, we regressed the six motion covariates from the functional images 
to further reduce its effects.  
There are concerns about the impact of cortical atrophy in functional connectivity studies. 
Cortical density differences between groups were not broad in our participants due to their 
early disease stage and were only significant when comparing HCs and PD-MCI patients 
(HC > PD-MCI) and delimited within the insula cortices which agrees with previous structural 
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studies (Duncan, et al., 2015), see Supplementary Material. Previous investigations in rs-
fMRI have proven that cortical density differences do not alter the position of the significant 
functional clusters, although their size may be slightly decreased (Damoiseaux, et al., 2012). 
Hence, we are confident that the small structural differences between HCs and PD-MCI 
patients did not affect our functional findings. 
Finally in the present study we did not carry out any reliability testing of our 
probabilistic group ICA procedure which is a potential limitation (Abou-Elseoud, et al., 
2010). There are, however, emerging reliability procedures (albeit it is not established 
by consensus which approach is better) which may be useful to apply in the future to 
our data and others to confirm the reliability of the group ICA maps.  
 
Conclusion 
We reported changes in functional connectivity in patients diagnosed with PD-NC and PD-
MCI using the level II MDS criteria. Our findings suggest that functional alterations in RSNs 
are more evident in our PD-NC group than in our PD-MCI group when compared to each 
other and against HCs. Most of these alterations were in RSNs associated to attention, 
motor control, visual and executive functions. 
Altered functional synchronisations were found between RSN activity and several brain 
regions in PD-NC. When assessing connectivity among RSNs with FSL-Nets, the PD-NC 
group showed higher synchronisation values for cortico-basal networks, which was also 
present in the PD-MCI group although not to a significant level. Finally, we observed shifts in 
the sign of the synchronisation in the PD groups which might be related to the disease stage 
and compensatory brain mechanisms. Longitudinal studies observing this transition will shed 
more light on the pathophysiological alterations in brain connectivity that are driven by PD. 
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Figure 1. Resting state networks (RSNs) inferred from the HC group using group ICA (MELODIC). A 
total of 70 independent components were estimated and 26 of them identified as of biological 
interest according to the previous literature. Similarly RSN names were assigned following 
convention in previous literature when possible; otherwise names were given according to the 
highest positive region in the RSN map. Brain maps are shown in radiological convention. 
 
Figure 2. Dual-regression results for between group comparisons: HC vs. PD-NC, HC vs. PD-MCI, and 
PD-NC vs. PD-MCI. Regions and MNI coordinates are described in Table II. HC – healthy controls, PD-
NC – PD with normal cognition, PD-MCI – PD with mild cognitive impairment, DAN – dorsal attention 
network, RFPN – right fronto-parietal network, MN2 – motor network 2, FPN – fronto-polar network, 
LFPN – left fronto-parietal network, VN2 – visual network 2, TEMP – temporal network, dmPFN – 
dorso-medial prefrontal network, CBN2 – cerebellar network 2. Brain maps are presented in 
radiological convention, i.e. right is left hemisphere. 
 
Figure 3. Cluster mean values from the significant differences shown in Figure 2 and Table II as 
boxplots. A) HC vs PD-NC, B) HC vs PD-MCI, and C) PD-NC vs PD-MCI.  Note: although some results 
are reported as decreased synchronisations in the patient group, e.g. HC > PD-NC in panel B), some 
of the findings relate to correlations shifting from positive in the healthy control (HC) group to 
negative correlations in the disease group, for example cluster VN2-25 (visual network 2, cluster 25) 
in panel B. Resting state network acronyms and clusters codes are described in Figure 1 and Table II 
respectively. HC - healthy controls, PD-NC - PD with normal cognition, PD-MCI - PD with mild 
cognitive impairment. In each boxplot, the central mark is the sample median and the extremes are 
the 25
th
 and 75
th
 percentiles. 
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Figure 4. FSL-Net group connectivity matrices. Panels A to C show FSL-Net normalised covariance 
matrices from the three participant groups; healthy controls (HCs), PD with normal cognition (PD-
NC) and with mild cognitive impairment (PD-MCI); for displaying purposes, matrices are not adjusted 
for confounding covariates. D) The PD-NC group showed significant higher connectivity between 
basal network BS1 and motor network MN1 with a shift from negative to positive synchronisation 
(*p-value < 0.05 FWE corrected for multiple comparisons, and corrected for age, gender, levodopa 
equivalent daily dose and years for education which were included as covariates of not interest). 
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Figure 1. Resting state networks (RSNs) inferred from the HC group. A total of 70 independent components 
were estimated and 26 of them identified as of biological interest according to the previous literature. 
Similarly RSN names were assigned following convention in previous literature when possible; otherwise 
names were given according to the highest positive region in the RSN map. Brain maps are shown in 
radiological convention.  
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Figure 2. Dual-regression results for between group comparisons: HC vs. PD-NC, HC vs. PD-MCI, and PD-NC 
vs. PD-MCI. Regions and MNI coordinates are described in Table II. HC – healthy controls, PD-NC – PD with 
normal cognition, PD-MCI – PD with mild cognitive impairment, DAN – dorsal attention network, RFPN – 
right fronto-parietal network, MN2 – motor network 2, FPN – fronto-polar network, LFPN – left fronto-
parietal network, VN2 – visual network 2, TEMP – temporal network, dmPFN – dorso-medial prefrontal 
network, CBN2 – cerebellar network 2. Brain maps are presented in radiological convention, i.e. right is left 
hemisphere.  
Figure 2  
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Figure 3. Cluster mean values from the significant differences shown in Figure 2 and Table II as boxplots. A) 
HC vs PD-NC, B) HC vs PD-MCI, and C) PD-NC vs PD-MCI.  Note: although some results are reported as 
decreased synchronisations in the patient group, e.g. HC > PD-NC in panel B), some of the findings relate to 
correlations shifting from positive in the healthy control (HC) group to negative correlations in the disease 
group, for example cluster VN2-25 (visual network 2, cluster 25) in panel B. Resting state network 
acronyms and clusters codes are described in Figure 1 and Table II respectively. HC - healthy controls, PD-
NC - PD with normal cognition, PD-MCI - PD with mild cognitive impairment. In each boxplot, the central 
mark is the sample median and the extremes are the 25th and 75th percentiles.  
Figure 3  
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Figure 4. FSL-Net group connectivity matrices. Panels A to C show FSL-Net normalised covariance matrices 
from the three participant groups; healthy controls (HCs), PD with normal cognition (PD-NC) and with mild 
cognitive impairment (PD-MCI); for displaying purposes, matrices are not adjusted for confounding 
covariates. D) The PD-NC group showed significant higher connectivity between basal network BS1 and 
motor network MN1 with a shift from negative to positive synchronisation (*p-value < 0.05 FWE corrected 
for multiple comparisons, and corrected for age, gender, levodopa equivalent daily dose and years for 
education which were included as covariates of not interest).  
Figure 4  
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Table I. Demographics and clinical variables 
 Healthy 
Controls 
PD-NC;  
Mean (SD) 
PD-MCI; 
Mean (SD) 
Significance, p-value 
Number of 
participants 
N=30 N=62 N=37  
Age 64.05 (7.92) 62.77 (10.83) 70.40 (9.13) F(2,126)=7.39, p=0.001† 
Male/Female 17/13 37/25 28/9 Χ
2
=3.36, p=0.186 
Education (years) 14.13 (3.65) 14.32 (3.9) 10.97 (3.24) p<0.001 * 
NART 118.6(6.96) 117.47(9.6), 
N=61 
112.52(9.5), 
N=36 
p=0.008 * 
Disease duration 
(months). 
NA 6.43 (4.76) 5.81 (4.51) p=0.458 ⱡ 
LEDD NA 147.06 (112.0) 201.59 (155.8) t97=2.01, p=0.046 
MDS-UPDRS III NA 24.59 (10.39) 28.86 (10.97) t97=1.93, p=0.056 
MMSE 29.36 (0.88) 29.01 (0.93) 28.18 (1.48) t97=3.4, p=0.001 
MoCA 28.2 (1.78), 
N=29 
26.92 (2.30), 
N=53 
22.97 (3.64), 
N=34 
t85=6.2, p<0.001 
Power of Attention 1217.46 
(101.175) 
1289.36 
(126.98), N=61 
1400.65 
(172.04) 
t96=3.6, p<0.001 
Digit Vigilance 
Accuracy 
98.0 (2.5) 97.59 (3.91), 
N=61 
83.9 (17.27) p<0.001 ⱡ 
PRM 21.89 (1.61), 
N=29 
21.15 (2.2), 
N=58 
18.02 (2.8), 
N=36 
p<0.001 ⱡ 
SRM 17.27 (1.22), 
N=29 
16.08 (1.7) 
N=58 
14.11 (2.5), 
N=36 
p<0.001 ⱡ 
Tower of London 17.44 (1.76), 
N=29 
15.68 (2.25), 
N=58 
12.88 (4.1), 
N=36 
p<0.001 ⱡ 
Animal naming NA 23.9 (5.58), 
N=60 
17.57 (6.6), 
N=35 
t93=4.97, p=<0.001 
Language total 
score 
NA 24.45 (7.29), 
N=50 
19.29 (6.6), 
N=32 
t80=3.24, p=0.002 
PAL NA 1.70 (0.43), 
N=58 
2.42 (0.83), 
N=35 
p<0.001 ⱡ 
NART, national adult reading test; LEDD, Levodopa equivalent daily dose; MDS-UPDRS III, Movement 
Disorder Society – unified Parkinson’s disease rating scale part III; MMSE, mini-mental state 
examination; MoCA, Montreal cognitive assessment; NA, not available; PRM, pattern recognition 
memory; SRM, spatial recognition memory; PAL, paired associates learning; SD, standard deviation. 
†ANOVA: healthy controls, PD-NC, and PD-MCI 
Χ
2 
test Healthy controls, PD-NC, and PD-MCI 
*Kruskal Wallis test, Healthy controls, PD-NC, PD-MCI; Post-hoc Mann-Whitney U: Age, PD-NC < PD-
MCI p-value <0.001;  NART, PD-NC > PD-MCI p-value =0.005. 
ⱡMann-Whitney U test; PD-NC and PD-MCI 
Student t-tests: PD-NC and PD-MCI 
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Table II. Dual-regression results from the between group comparisons; corrected for multiple 
comparisons with threshold-free cluster enhancement (TFCE, p-value<0.05). L/R, right and left 
hemisphere.  
Dual-regression, 
cluster index 
Number 
of Voxels  
Min p-
value 
MNI 
coordinate 
Brain regions – Harvard-Oxford atlas 
HC > PD-NC     
RFPN-01 10 0.024 42,-38,36 R supramarginal gyrus 
DAN-02 158 0.009 38,-2,40 R precentral gyrus, R middle frontal gyrus 
DAN-03 144 0.005 58,-6,44 R precentral gyrus, R postcentral gyrus 
DAN-04 43 0.017 -6,-14,60 L supplementary motor area, L precentral gyrus. 
DAN-05 34 0.022 -10,-62,64 L lateral occipital cortex, L precuneus cortex 
DAN-06 20 0.022 50,50,4 R frontal pole 
DAN-07 18 0.036 18,-6,64 R superior frontal gyrus 
DAN-08 17 0.038 62,-14,8 R planum temporale 
DAN-09 8 0.04 -14,-46,76 L postcentral gyrus 
DAN-10 5 0.038 -10,-78,52 L lateral occipital cortex, superior division 
DAN-11 3 0.03 -66,-50,36 L supramarginal gyrus, posterior division 
DAN-12 2 0.048 -18,-78,52 L lateral occipital cortex, superior division 
DAN-13 1 0.048 42,-82,24 R lateral occipital cortex, superior division 
MN2-14 601 0.001 -42,-78,40 L lateral occipital cortex, R cuneal cortex, R occipital 
cortex, L precentral gyrus, R lateral occipital cortex  
MN2-15 73 0.026 26,-54,72 R superior parietal lobule 
MN2-16 32 0.013 34,26,16 R inferior frontal gyrus, pars opercularis 
MN2-17 5 0.042 -10,-18,36 L cingulate gyrus, posterior division 
MN2-18 3 0.044 62,6,-4 R superior temporal gyrus, anterior division 
MN2-19 2 0.05 2,-62,36 R precuneus cortex 
FPN-20 192 0.013 38,-26,64 
R postcentral gyrus, R middle frontal gyrus, R superior 
parietal lobule, R precentral gyrus. 
FPN-21 25 0.014 38,22,32 R middle frontal gyrus 
FPN-22 17 0.039 46,-46,60 R superior parietal lobule 
HC < PD-NC     
LFPN-23 9 0.031 -10,26,-4 L subcallosal cortex. 
HC > PD-MCI     
TEMP-24 30 0.02 62,6,40 R precentral gyrus. 
VN2-25 22 0.019 -42,-18,56 L precentral gyrus. 
DAN-26 8 0.031 50,50,0 R frontal pole. 
PD-NC > PD-MCI     
RFPN-27 1 0.043 -2,-62,36 L precuneus cortex. 
VAN-28 22 0.025 18,-10,40 R precentral gyrus, R cingulate gyrus. 
VAN-29 21 0.018 58,-2,40 R precentral gyrus. 
VAN-30 9 0.046 2,-6,32 R cingulate gyrus, anterior division. 
VAN-31 2 0.05 -2,22,64 L superior frontal gyrus. 
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dmPFN-32 738 0.007 -26,6,68 
L middle frontal gyrus, L precentral gyrus, L postcentral 
gyrus, R supplementary motor cortex. 
dmPFN--33 56 0.017 14,62,-8 R frontal pole, L frontal pole. 
dmPFN--34 25 0.033 18,-54,76 R superior parietal lobule. 
dmPFN--35 9 0.031 -26,50,36 L frontal pole. 
dmPFN--36 6 0.043 34,54,-16 R frontal pole. 
dmPFN--37 4 0.046 42,10,60 R middle frontal gyrus. 
dmPFN--38 4 0.04 -6,54,44 L frontal pole. 
dmPFN--39 2 0.04 6,66,24 R frontal pole. 
dmPFN--40 2 0.046 -22,66,16 L frontal pole. 
dmPFN--41 1 0.05 46,26,48 R middle frontal gyrus. 
dmPFN--42 1 0.05 54,18,44 R middle frontal gyrus. 
dmPFN--43 1 0.049 62,2,40 R precentral gyrus. 
PD-NC < PD-MCI     
INSN-44 5 0.034 -46,-70,48 L lateral occipital cortex, superior division. 
CBN2-45 25 0.016 6,30,-28 R subcallosal cortex, R frontal pole. 
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Table III. Multiple regression results between significant cluster from the dual-regression 
analysis and clinical variables from the MCI diagnostic criteria. Cluster significance was 
assessed with FSL-randomise with threshold free cluster enhancement (TFCE) correction 
for multiple comparisons. YoE, years of education; LEDD, Levodopa equivalent daily dose; 
GLM, general linear model; PoA, power of attention; ToL, Tower of London; R/L, right and 
left hemisphere. 
Dual-
regression 
TFCE GLM corrected 
clusters 
GLM: Voxel ~ B1*variable + age + gender + YoE + LEDD 
HC vs  
PD-NC Variable 
Number 
of voxels B1 
Min p-
value 
MNI 
coordinate Brain region  
LFPN-23 PRM 6 0.23716 0.0028 -6,30,-8 L subcallosal cortex 
LFPN-23  ToL 1 0.18869 0.0074 -6,26,-4 L subcallosal cortex 
MN2-14 PoA 7 0.005 0.0012 -30,-94,24 L occipital pole 
MN2-14 PoA 3 0.0059 0.00053 34,-86,40 R cerebral cortex 
MN2-14 PoA 1 0.00591 0.00063 -46,-82,28 L cerebral cortex 
FPN-20 SRM 4 0.47865 
9.10E-
005 38,18,56 R middle frontal gyrus 
FPN-20 SRM 3 0.41244 0.0011 18,-46,76 R superior parietal lobule 
FPN-20 SRM 2 0.40269 0.0029 38,-2,68 R precentral gyrus 
FPN-20 SRM 1 0.36416 0.0023 22,-26,80 R postcentral gyrus 
FPN-22 UPDRS 2 -0.073 0.00046 42,-46,68 R superior parietal lobule 
FPN-22 UPDRS 2 -0.08 0.00053 42,-50,68 R superior Parietal lobule 
HC vs  
PD-MCI 
LFPN-23 SRM 1 -0.2610 0.0025 -30,38,24 L frontal pole 
TEMP-24 PAL 1 -0.7557 0.0021 62,6,36 R precentral gyrus 
VN2-25 PAL 3 -0.9386 0.0088 -46,-18,52 L postcentral gyrus 
PD-NC vs 
PD-MCI 
VAN-28 MoCA 2 0.13936 0.002277 26,-10,40 R precentral gyrus 
VAN-28 MoCA 1 0.11588 0.0042 18,-18,40 
R cingulate gyrus, 
posterior division 
VAN-28 PRM 10 0.16192 0.0002 18,-14,40 
R cingulate gyrus, anterior 
division 
dmPFN-32 ToL 13 0.0036 0.00064 -34,-10,76 L precentral gyrus 
dmPFN-32 ToL 6 0.0037 0.0022 -30,-38,72 L postcentral gyrus 
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